FibroGen
FGEN
$1.04
Share price
1.96%
Change (1 day)
-93.93%
Change (1 year)
Categories
FibroGen (FGEN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.58 B
According to FibroGen's latest financial reports the company's total liabilities are $0.58 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
FibroGen - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.58 B | -4.23% |
| 2022-12-31 | $0.61 B | 12.27% |
| 2021-12-31 | $0.54 B | 41.34% |
| 2020-12-31 | $0.38 B | 19.69% |
| 2019-12-31 | $0.32 B | -8.56% |
| 2018-12-31 | $0.35 B | 0.35% |
| 2017-12-31 | $0.35 B | 19.18% |
| 2016-12-31 | $0.29 B | 7.56% |
| 2015-12-31 | $0.27 B | 12.72% |
| 2014-12-31 | $0.24 B | 28.26% |
| 2013-12-31 | $0.18 B | 32.04% |
| 2012-12-31 | $0.14 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $4.36 B | 645.40% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | $51.25 M | -91.25% | 🇺🇸 USA |